408 results
Page 7 of 21
6-K
EX-99.1
6cuuw2b2ryfdoa5o1
21 Jul 14
Live Filing
12:00am
6-K
EX-99.1
kkqmpms
14 Jul 14
First Breath-Actuated Dry-Powder SABA Inhaler to be Accepted by FDA for Review
12:00am
6-K
EX-99.1
s7i60isnuq
3 Jul 14
Current report (foreign)
12:00am
6-K
EX-99.1
l6qzv 6q4t72sre6
20 Jun 14
Teva Reaches Settlement In Proair®hfa Patent Case
12:00am
6-K
9cxc4xi1nvt8hj
18 Jun 14
Current report (foreign)
12:00am
6-K
EX-99.1
293rl r0t
17 Jun 14
Teva Reaches Settlements In Nuvigil® Patent Case
12:00am
6-K
EX-99.1
9sxxf85y k520f84yqq
12 Jun 14
Teva Announces U.s. Court of Appeals Upholds Ruling Confirming Invalidity of Baraclude® Patent
12:00am
6-K
EX-99.1
kmiujz8e34k3991fsts
9 Jun 14
FDA Approves Expanded Label for AZILECT® for Treatment Across All Stages of Parkinson’s Disease
12:00am
6-K
EX-99.1
5i64khf8xy7j3s2iqwiu
3 Jun 14
Live Filing
12:00am
6-K
EX-99.1
20j1icelul sicxerm1
2 Jun 14
Appoints Sigurdur Olafsson As President and Ceo of Newly Established Global Generic Medicines Group
12:00am
6-K
EX-99.1
ds64qc7voqsp59t
30 May 14
Teva Receives Favorable Court Decision Regarding Generic Celebrex ® Capsules; Teva should receive sole exclusivity for generic Celebrex ® Capsules
12:00am
6-K
EX-99.1
hwvil5hf3q6wbll6e
27 May 14
Teva Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding
12:00am
6-K
EX-99.1
064azy
23 May 14
Teva Received FDA Approval for QVAR® (beclomethasone dipropionate HFA) with Dose Counter
12:00am
6-K
EX-99.1
1h0268284t89j5c
29 Apr 14
Teva Receives European Marketing Authorization for DuoResp Spiromax® for the Treatment of Asthma and COPD
12:00am
6-K
EX-99.1
vcp nyfzjicxf214kddf
28 Apr 14
Live Filing
12:00am
6-K
EX-99.1
ria2y56ln3
28 Apr 14
Teva and Takeda Agree to Commercialize Rasagiline for Parkinson’s Disease Treatment In Japan
12:00am
6-K
EX-99.1
w4vpy1j4h qs4qi2x
24 Apr 14
Pride-hd Study Enrolling Patients Globally to Further Evaluate Pridopidine for the Symptomatic Treatment of Huntington’s Disease
12:00am
6-K
EX-99.1
ezmtpsc3qxec
21 Apr 14
Live Filing
12:00am
6-K
EX-99.1
030c16n
15 Apr 14
Teva Announces Launch of Generic Lunesta® Tablets In the United States
12:00am
6-K
EX-99.1
10u8u4njvzc
8 Apr 14
Teva Announces First Approval and Launch of Generic Lovaza®capsules In the United States
12:00am